Table 1.
Clinical and biochemical features of the studied population
| COVID-19 (n = 239) | Non-COVID-19 (n = 262) | p value | |
|---|---|---|---|
| Age, years | 63.7 (18.1) | 64.9 (19.3) | 0.468 |
| Males, n (%) | 139 (58.2%) | 138 (52.7%) | 0.217 |
| BMI, Kg/m2 | 26.84 (5.3) | 26.33 (4.0) | 0.513 |
| CT pneumonia, n (%) | 188 (78.7%) | 83 (31.7%) | <0.0001 |
| 30-day deaths, n (%) | 38 (15.8%) | 32 (12.2%) | 0.234 |
| 120-day deaths, n (%) | 52 (21.8%) | 46 (17.6%) | 0.236 |
| Vertebral fractures, n (%) | 53 (22.2%) | 50 (19%) | 0.458 |
| Single fracture, n (%) | 30 (12.6%) | 20 (7.6%) | 0.066 |
| Multiple fractures, n (%) | 23 (9.6%) | 30 (11.5%) | 0.506 |
| Bone density, HU | 130.8 (58.6) | 119.3 (55.3) | 0.086 |
The table reports comparisons between the subjects with COVID-19 and subjects without COVID-19 (non-COVID-19 group)